a study on Adenovirus
Provide patients with serious AdV infection or disease access to treatment with BCV.
An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Adenovirus Adenovirus Brincidofovir
Open to people ages 2 months and up
This step makes sure spammers don’t flood our inbox
We will not share your information with anyone other than the team in charge of this study. Submitting your contact information does not obligate you to participate in research.
The study team should get back to you in a few business days.
You will also receive an email with next steps. Check your junk/spam folder if needed.
If you do not hear from the study team, please call 888-689-8273 and tell them you’re interested in study number NCT02596997.
© 2017 The Regents of the University of California